California’s Cannabis Testing Requirements Leave Gaps, Exposing Consumers to Unknown Risks
A recent investigation by the Los Angeles Times has revealed significant gaps in California’s testing requirements for cannabis products, leaving consumers exposed to unknown risks. To better understand the issue, the Times purchased over 150 products from licensed stores, tobacco shops, and illicit vendors, and had them tested at three state-licensed labs without revealing the brand names.
The tests, which included expanded screening for over 290 pesticides and checks for hazardous materials such as vitamin E acetate and synthetic cannabinoids, were conducted at Anresco Laboratories, SC Labs, and Infinite Chemical Analysis Labs. The investigation also obtained data from private market tests conducted on behalf of vape manufacturer Raw Garden and the March and Ash dispensary chain.
The results of the tests show that many products contain pesticides, synthetic THC, and harmful dilution oils. Most of the products tested were vapes purchased on the legal market, with some pre-rolls, edibles, and products bought outside of legal venues also included.
The tests found that many products exceeded California’s limits for pesticides, with some containing pesticides not even listed on the state’s mandatory screening list. Pesticides pose a particular threat in inhaled cannabis products, as they can enter the lungs and travel through the bloodstream to internal organs, including the brain.
While the risks from one-time use may be minimal, repeated exposure over time can increase the risks. The investigation highlights the need for stricter testing requirements and more transparency in the cannabis industry to ensure consumer safety.
The full results of the tests can be found in the article, with each product listed along with its findings. The investigation also provides more information on the risks posed by pesticides and the need for stricter regulations in the cannabis industry.
